Further Evidence from Functional Studies for Somatostatin Receptor Heterogeneity in Guinea-pig Isolated Ileum, Vas Deferens and Right Atrium

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1995 Jul 1

PMID 7582529

Citations 5

Authors

W Feniuk

J Dimech

E M Jarvie

P P Humphrey

Affiliations

Soon will be listed here.

Abstract

1. Somatostatin (SRIF) causes a concentration-dependent inhibition of neurotransmission in guinea-pig ileum and vas deferens as well as negative inotropy in guinea-pig isolated right atrium. The SRIF receptors mediating these effects have now been further characterized by use of the peptides BIM-23027, BIM-23056 and L-362855, reported as selective for the recombinant SRIF receptor types, sst2, sst3 and sst5, respectively. 2. BIM-23027 was a highly potent agonist at causing an inhibition of neurotransmission in the guinea-pig ileum (EC50 value 1.9 nM), being about 3 times more potent than SRIF (EC50 value 6.8 nM). In contrast, in both guinea-pig vas deferens and right atrial preparations, BIM-23027 was a relatively weak agonist being at least 30-100 times weaker than SRIF. In guinea-pig atria, BIM-23027 (3 microM) antagonized the negative inotropic action of SRIF28 (apparent pKB = 5.9 +/- 0.1) but had no effect on the negative inotropic action of cyclohexyladenosine. 3. The inhibitory effect of BIM-23027 in the guinea-pig ileum was readily desensitized. Prior exposure to BIM-23027 (0.3 microM) markedly attenuated the inhibitory effect of SRIF but had no effect on the inhibitory action of clonidine suggesting that BIM-23027 and SRIF act via a common receptor mechanism. 4. L-362855 caused a concentration-dependent inhibition of neurotransmission in both the guinea-pig ileum and vas deferens as well as causing negative inotropy in the guinea-pig atrium but was at least 30-100 times weaker than SRIF. In guinea-pig isolated atria, L-362855 (3 microM) did not antagonize the negative inotropic action of SRIF28. 5. BIM-23056 in concentrations up to 1 microM was inactive as an agonist in guinea-pig isolated ileum, vas deferens and atrium and did not antagonize the inhibitory actions of SRIF in any of these preparations.6. The results from this study support our previous contention that the sst2 receptor type mediates inhibition of neurotransmission by SRIF in the guinea-pig ileum. The SRIF receptor type mediating inhibition of neurotransmission in the guinea-pig vas deferens appears different, but similar, to that mediating negative inotropy in the atrium. However the characteristics of these latter receptors appear different from that of the recombinant sst2, sst3 and sst5 receptors for SRIF described for rat and man.

Citing Articles

Agonists, Antagonists and Receptors of Somatostatin: Pathophysiological and Therapeutical Implications in Neoplasias.

Periferakis A, Tsigas G, Periferakis A, Tone C, Hemes D, Periferakis K Curr Issues Mol Biol. 2024; 46(9):9721-9759.

PMID: 39329930 PMC: 11430067. DOI: 10.3390/cimb46090578.

Pharmacological examination of contractile responses of the guinea-pig isolated ileum produced by mu-opioid receptor antagonists in the presence of, and following exposure to, morphine.

Mundey M, Ali A, Mason R, Wilson V Br J Pharmacol. 2000; 131(5):893-902.

PMID: 11053208 PMC: 1572416. DOI: 10.1038/sj.bjp.0703659.

Operational characteristics of somatostatin receptors mediating inhibitory actions on rat locus coeruleus neurones.

Chessell I, Black M, Feniuk W, Humphrey P Br J Pharmacol. 1996; 117(8):1673-8.

PMID: 8732275 PMC: 1909561. DOI: 10.1111/j.1476-5381.1996.tb15338.x.

Differences in the operational characteristics of the human recombinant somatostatin receptor types, sst1 and sst2, in mouse fibroblast (Ltk-) cells.

Castro S, Buell G, Feniuk W, Humphrey P Br J Pharmacol. 1996; 117(4):639-46.

PMID: 8646408 PMC: 1909325. DOI: 10.1111/j.1476-5381.1996.tb15238.x.

Somatostatin receptors mediating inhibition of basal and stimulated electrogenic ion transport in rat isolated distal colonic mucosa.

McKeen E, Feniuk W, Humphrey P Naunyn Schmiedebergs Arch Pharmacol. 1995; 352(4):402-11.

PMID: 8532068 DOI: 10.1007/BF00172777.

References

Mandarino L, Stenner D, Blanchard W, Nissen S, Gerich J, Ling N . Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion. Nature. 1981; 291(5810):76-7. DOI: 10.1038/291076a0. View

Hoyer D, Bell G, Berelowitz M, Epelbaum J, Feniuk W, Humphrey P . Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci. 1995; 16(3):86-8. DOI: 10.1016/s0165-6147(00)88988-9. View

Law S, Yamada Y, Seino S, Bell G, Reisine T . Pharmacological properties of two cloned somatostatin receptors. Mol Pharmacol. 1992; 42(1):28-34. View

Vanetti M, Kouba M, Wang X, Vogt G, Hollt V . Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett. 1992; 311(3):290-4. DOI: 10.1016/0014-5793(92)81122-3. View

Bruno J, Xu Y, Song J, Berelowitz M . Molecular cloning and functional expression of a brain-specific somatostatin receptor. Proc Natl Acad Sci U S A. 1992; 89(23):11151-5. PMC: 50507. DOI: 10.1073/pnas.89.23.11151. View

OCarroll A, Lolait S, Konig M, Mahan L . Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28. Mol Pharmacol. 1992; 42(6):939-46. View

Raynor K, Murphy W, Coy D, Taylor J, Moreau J, Yasuda K . Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol Pharmacol. 1993; 43(6):838-44. View

Dimech J, Feniuk W, Humphrey P . Antagonist effects of seglitide (MK 678) at somatostatin receptors in guinea-pig isolated right atria. Br J Pharmacol. 1993; 109(4):898-9. PMC: 2175736. DOI: 10.1111/j.1476-5381.1993.tb13703.x. View

Reisine T, Kong H, Raynor K, Yano H, Takeda J, Yasuda K . Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase. Mol Pharmacol. 1993; 44(5):1016-20. View

10.

Rossowski W, Coy D . Potent inhibitory effects of a type four receptor-selective somatostatin analog on rat insulin release. Biochem Biophys Res Commun. 1993; 197(2):366-71. DOI: 10.1006/bbrc.1993.2488. View

11.

Patel Y, Panetta R, Escher E, Greenwood M, Srikant C . Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype. J Biol Chem. 1994; 269(2):1506-9. View

12.

Feniuk W, Dimech J, Humphrey P . Characterization of somatostatin receptors in guinea-pig isolated ileum, vas deferens and right atrium. Br J Pharmacol. 1993; 110(3):1156-64. PMC: 2175805. DOI: 10.1111/j.1476-5381.1993.tb13935.x. View

13.

OCarroll A, Raynor K, Lolait S, Reisine T . Characterization of cloned human somatostatin receptor SSTR5. Mol Pharmacol. 1994; 46(2):291-8. View

14.

Patel Y, Srikant C . Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology. 1994; 135(6):2814-7. DOI: 10.1210/endo.135.6.7988476. View

15.

Kurokawa M, Kirk I, Kirkpatrick K, Kase H, Richardson P . Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release. Br J Pharmacol. 1994; 113(1):43-8. PMC: 1510043. DOI: 10.1111/j.1476-5381.1994.tb16171.x. View

16.

Feniuk W, Humphrey P . Somatostatin-induced inhibition of neurotransmission in the mouse isolated vas deferens is resistant to pertussis toxin. Eur J Pharmacol. 1994; 261(3):333-7. DOI: 10.1016/0014-2999(94)90126-0. View

17.

McKeen E, Feniuk W, Humphrey P . Mediation by SRIF1 receptors of the contractile action of somatostatin in rat isolated distal colon; studies using some novel SRIF analogues. Br J Pharmacol. 1994; 113(2):628-34. PMC: 1510125. DOI: 10.1111/j.1476-5381.1994.tb17036.x. View

18.

Amherdt M, Patel Y, Orci L . Selective binding of somatostatin-14 and somatostatin-28 to islet cells revealed by quantitative electron microscopic autoradiography. J Clin Invest. 1987; 80(5):1455-8. PMC: 442403. DOI: 10.1172/JCI113225. View